Uyarel Huseyin, Ergelen Mehmet, Cicek Gokhan, Kaya Mehmet Gungor, Ayhan Erkan, Turkkan Ceyhan, Yıldırım Ersin, Kırbas Veli, Onturk Ebru Tekbas, Erer Hatice Betul, Yesilcimen Kemal, Gibson C Michael
Department of Cardiology, Balikesir University, School of Medicine, Cagis Campus, Balikesir, Turkey.
Coron Artery Dis. 2011 May;22(3):138-44. doi: 10.1097/MCA.0b013e328342c77b.
Red cell distribution width (RDW), a measure of red blood cell size heterogeneity, was evaluated in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).
Higher RDW is associated with mortality in patients with symptomatic cardiovascular disease, heart failure, and also in the general population. We hypothesized that admission RDW would be predictive of adverse outcomes in patients after primary PCI.
Two thousand five hundred and six consecutive STEMI patients (mean age 56.6±11.8 years; 2075 males, 431 females) undergoing primary PCI were retrospectively enrolled into this study. Admission RDW was measured as part of the automated complete blood count. Patients were grouped as elevated or nonelevated RDW using the upper limit of normal value of 14.8% and were followed for in-hospital and long-term outcomes for a mean period of 1.8±1.3 years (median 21 months).
A higher in-hospital mortality rate was observed among patients with elevated admission RDW (mean 16.1±1.6%) compared with those with nonelevated RDW (mean 13.4±0.8%) (7.6 vs. 3.6%, P<0.001). The long-term cardiovascular prognosis was worse for patients with elevated admission RDW (Kaplan-Meier, log-rank P<0.001). We used Cox proportional hazard models to examine the association between RDW and adverse clinical outcomes. After discharge, there were 129 deaths during follow-up. A significant association was noted between elevated admission RDW level and the adjusted risk of cardiovascular mortality (hazard ratio: 1.831, 95% confidence interval: 1.034-3.24, P=0.03). In addition, elevated admission RDW was also an independent predictor of cardiovascular mortality in the nonanemic subpopulation of patients (hazard ratio: 2.703, 95% confidence interval: 1.208-6.048, P=0.016).
A high admission RDW level in patients with STEMI undergoing primary PCI was associated with increased risk for in-hospital and long-term cardiovascular mortality.
对接受ST段抬高型心肌梗死(STEMI)直接经皮冠状动脉介入治疗(PCI)的患者评估红细胞分布宽度(RDW),这是一种衡量红细胞大小异质性的指标。
较高的RDW与有症状心血管疾病、心力衰竭患者及普通人群的死亡率相关。我们推测入院时的RDW可预测直接PCI术后患者的不良结局。
本研究回顾性纳入了2506例连续接受直接PCI的STEMI患者(平均年龄56.6±11.8岁;男性2075例,女性431例)。入院时的RDW作为自动全血细胞计数的一部分进行测量。采用14.8%的正常上限值将患者分为RDW升高组或未升高组,并对其进行平均1.8±1.3年(中位数21个月)的住院及长期结局随访。
入院时RDW升高的患者(平均16.1±1.6%)与RDW未升高的患者(平均13.4±0.8%)相比,住院死亡率更高(7.6%对3.6%,P<0.001)。入院时RDW升高的患者长期心血管预后更差(Kaplan-Meier法,对数秩检验P<0.001)。我们使用Cox比例风险模型来研究RDW与不良临床结局之间的关联。出院后,随访期间有129例死亡。入院时RDW水平升高与心血管死亡的校正风险之间存在显著关联(风险比:1.831,95%置信区间:1.034 - 3.24,P = 0.03)。此外,入院时RDW升高也是患者非贫血亚组中心血管死亡的独立预测因素(风险比:2.703,95%置信区间:1.208 - 6.048,P = 0.016)。
接受直接PCI的STEMI患者入院时RDW水平较高与住院及长期心血管死亡风险增加相关。